Rob Geiger

[Rob Geiger @peptide2025]

@DarrenWillcox1 @viktorfogland Maroons!

[Rob Geiger @peptide2025]

@hubermanlab @Molle333 We will never see the amino acids (start of the magic) being made in the USA

[Rob Geiger @peptide2025]

@DrJesseMorse Moving away from problematic Chinese API supply chains doesn't mean US manufacturing is the only fix. India is the ideal partner here: robust FDA-inspected API manufacturing infrastructure, deep chemical synthesis talent, and cost efficiencies that keep drugs accessible.

[Rob Geiger @peptide2025]

@isaacbklein Next, he is going to tell us Semaglutide is pronounced “See-mag-lutide”

[Rob Geiger @peptide2025]

@kevinace @maxmarchione Outer ring = diagnostic categories (Respiratory, etc.).
Colored bars = hazard ratios:
🔵 Blue = (benefit)
🔴 Red = (harm)
⬜ Gray = no sig difference
Bar height ≈ effect size. Center yellow spikes = statistical strength (taller = more). Labels call out specific conditions.

[Rob Geiger @peptide2025]

@FreddyLA7 @HSC1776 you will not regret a Saturday in Hampden-Sydney Virginia

[Rob Geiger @peptide2025]

@FreddyLA7 What weekend are you going to Helen?

[Rob Geiger @peptide2025]

@Mike_Scully_ AI

[Rob Geiger @peptide2025]

@kai_cabero siphon

[Rob Geiger @peptide2025]

@storeycopy LEAD

[Rob Geiger @peptide2025]

@fivosaresti LINKEDIN

[Rob Geiger @peptide2025]

@scaling_shields GHOST

[Rob Geiger @peptide2025]

@Pharma_Pro @mansizzzzle 39 vs 40 amino acid distinction has no biochemical basis. Doesn’t matter if it is made by chemical synthesis.
• Classification should be based on:
• Manufacturing method
• Structural complexity

The argument described is
regulatory engineering, not scientific reasoning